# FDA Inspection 1068422 - Vitalant - September 14, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/vitalant/ff622a5c-1c6e-460b-9612-5de21b9050aa/
Source feed: FDA_Inspections

> FDA Inspection 1068422 for Vitalant on September 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068422
- Company Name: Vitalant
- Inspection Date: 2018-09-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223522 - 2023-11-09](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/6d2b5749-1423-4899-b770-6b9d5b00edae/)
- [FDA Inspection 986029 - 2016-09-09](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/ab155ab1-febd-4eed-8c99-b05964c2eea4/)
- [FDA Inspection 870530 - 2014-03-14](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/db0e5f14-b519-4234-8327-f471b417b91a/)
- [FDA Inspection 724345 - 2011-05-11](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/c6edabd8-d79b-4cfd-809c-d035b5ff2b3e/)

Company: https://www.globalkeysolutions.net/companies/vitalant/029448da-c18b-462a-9437-1a6e9d7c2417

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d